BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13677417)

  • 1. Improving cardiovascular disease prevention and management in Africa: issues to consider for the 21st century.
    Madu EC; Richardson KD; Ozigbo OH; Baugh DS
    Ethn Dis; 2003; 13(2 Suppl 2):S71-6. PubMed ID: 13677417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heart-healthy and "stroke-free" world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa.
    Mensah GA
    Ethn Dis; 2003; 13(2 Suppl 2):S4-12. PubMed ID: 13677406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of cardiovascular disease burden in the United States.
    Mensah GA; Brown DW
    Health Aff (Millwood); 2007; 26(1):38-48. PubMed ID: 17211012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular diseases and risk factors in Finland.
    Vartiainen E; Puska P; Jousilahti P; Korhonen HJ
    Prev Med; 1999 Dec; 29(6 Pt 2):S124-9. PubMed ID: 10641830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health surveillance for disease prevention: lessons from the behavioral risk factor surveillance system.
    Mokdad AH; Bales VS; Greenlund KJ; Mensah GA
    Ethn Dis; 2003; 13(2 Suppl 2):S19-23. PubMed ID: 13677408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda?
    Unwin N; Setel P; Rashid S; Mugusi F; Mbanya JC; Kitange H; Hayes L; Edwards R; Aspray T; Alberti KG
    Bull World Health Organ; 2001; 79(10):947-53. PubMed ID: 11693977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the World Heart Federation in cardiovascular health promotion and disease prevention in developing countries with a special emphasis on sub-Saharan Africa.
    Wilson EE;
    Ethn Dis; 2003; 13(2 Suppl 2):S164-6. PubMed ID: 13677432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health promotion and cardiovascular disease prevention in sub-Saharan Africa.
    Sampson UK; Amuyunzu-Nyamongo M; Mensah GA
    Prog Cardiovasc Dis; 2013; 56(3):344-55. PubMed ID: 24267442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
    Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
    Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
    Gaziano TA
    Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population aging and implications for epidemic cardiovascular disease in Sub-Saharan Africa.
    Smith SM; Mensah GA
    Ethn Dis; 2003; 13(2 Suppl 2):S77-80. PubMed ID: 13677418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic considerations in the primordial prevention of cardiovascular disease.
    Kaplan GA; Lynch JW
    Prev Med; 1999 Dec; 29(6 Pt 2):S30-5. PubMed ID: 10641815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic heart disease in Africa.
    Mensah GA
    Heart; 2008 Jul; 94(7):836-43. PubMed ID: 18552223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular diseases, risk factors and barriers in their prevention in Croatia.
    Dzakula A; Sogorić S; Polasek O; Jurisa A; Andrić A; Radaković N; Todorović G
    Coll Antropol; 2009 Apr; 33 Suppl 1():87-92. PubMed ID: 19563152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Victoria Declaration--a unifying force.
    O'Connor B
    Can J Cardiol; 1995 Jan; 11 Suppl A():12A-13A. PubMed ID: 7850668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease.
    Pearson TA
    Ethn Dis; 2003; 13(2 Suppl 2):S158-63. PubMed ID: 13677431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of cardiovascular disease in Canada--a call to action.
    Svendsen A
    Can J Cardiovasc Nurs; 2004; 14(1):5-7. PubMed ID: 15022527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.